Access
To read this story in full you will need to login or make a payment (see right).
Letter
Nature 445, 643-647 (8 February 2007) | doi:10.1038/nature05506; Received 25 August 2006; Accepted 5 December 2006
Open Innovation Challenges
-
Efficient Chromosome Doubling: Plant Cell Division
The Seeker is looking for an efficient chromosome doubling method in plants and in particular, metho...
-
Fast Growth of Transformed Soybean Shoots
A method for accelerating growth of soybean shoots is desired.
nature jobs
Laboratory Manager / Principal Research Assistant
- Wellcome Trust Sanger Institute
- Hinxton, Cambridge, CB10 1SA, UK
Research Psychiatrist
- Scripps Research Institute
- La Jolla, CA
Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models
Anatol C. Kreitzer1,2 & Robert C. Malenka1
- Department of Psychiatry and Behavioral Sciences, Nancy Pritzker Laboratory, Stanford University Medical School, Palo Alto, California 94305, USA
- Present address: Gladstone Institute of Neurological Disease and Department of Physiology, University of California, San Francisco, San Francisco, California 94158, USA.
Correspondence to: Robert C. Malenka1 Correspondence and requests for materials should be addressed to R.C.M. (Email: malenka@stanford.edu).
Abstract
The striatum is a major forebrain nucleus that integrates cortical and thalamic afferents and forms the input nucleus of the basal ganglia1, 2. Striatal projection neurons target the substantia nigra pars reticulata (direct pathway) or the lateral globus pallidus (indirect pathway). Imbalances between neural activity in these two pathways have been proposed to underlie the profound motor deficits observed in Parkinson's disease and Huntington's disease3, 4. However, little is known about differences in cellular and synaptic properties in these circuits. Indeed, current hypotheses suggest that these cells express similar forms of synaptic plasticity5, 6. Here we show that excitatory synapses onto indirect-pathway medium spiny neurons (MSNs) exhibit higher release probability and larger N-methyl-d-aspartate receptor currents than direct-pathway synapses. Moreover, indirect-pathway MSNs selectively express endocannabinoid-mediated long-term depression (eCB-LTD), which requires dopamine D2 receptor activation. In models of Parkinson's disease, indirect-pathway eCB-LTD is absent but is rescued by a D2 receptor agonist or inhibitors of endocannabinoid degradation. Administration of these drugs together in vivo reduces parkinsonian motor deficits, suggesting that endocannabinoid-mediated depression of indirect-pathway synapses has a critical role in the control of movement. These findings have implications for understanding the normal functions of the basal ganglia, and also suggest approaches for the development of therapeutic drugs for the treatment of striatal-based brain disorders.
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Indirect-pathway neurons lose their spines in Parkinson diseaseNature Neuroscience News and Views (01 Feb 2006)
RESEARCH
Cerebral mitochondrial metabolism in early Parkinson's diseaseJournal of Cerebral Blood Flow & Metabolism Original Article
Cholinergic modulation of Kir2 channels selectively elevates dendritic excitability in striatopallidal neuronsNature Neuroscience Article (01 Nov 2007)
See all 15 matches for Research
